CIBMTR Reporting Implementation Guide
0.1.6 - Trial Use 1

This page is part of the CIBMTR Reporting Implementation Guide (v0.1.6: Release Draft) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions

: MedicationAdministration-Example2 - JSON Representation

Raw json | Download


{
  "resourceType" : "MedicationAdministration",
  "id" : "MedicationAdministration-Example2",
  "meta" : {
    "profile" : [
      "http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-medication-administration"
    ],
    "security" : [
      {
        "system" : "http://terminology.cibmtr.org/codesystem/transplant-center",
        "code" : "rc_99999",
        "display" : "99999 My Transplant Center"
      }
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicationAdministration</b><a name=\"MedicationAdministration-Example2\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicationAdministration &quot;MedicationAdministration-Example2&quot; </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-cibmtr-medication-administration.html\">CIBMTR Medication Administration (mcode)</a></p><p style=\"margin-bottom: 0px\">Security Labels: <span title=\"{http://terminology.cibmtr.org/codesystem/transplant-center http://terminology.cibmtr.org/codesystem/transplant-center}\">http://terminology.cibmtr.org/codesystem/transplant-center</span></p></div><p><b>status</b>: completed</p><p><b>medication</b>: ETOPOSIDE 20 MG/ML IV SOLN <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-v3-rxNorm.html\">RxNorm</a>#4179 &quot;etoposide&quot;; <a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-v3-rxNorm.html\">RxNorm</a>#310248 &quot;etoposide 20 MG/ML Injectable Solution&quot;; <a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-v3-rxNorm.html\">RxNorm</a>#362972 &quot;etoposide Injectable Solution [Vepesid]&quot;; <a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-v3-rxNorm.html\">RxNorm</a>#206832 &quot;etoposide 20 MG/ML Injectable Solution [Vepesid]&quot;)</span></p><p><b>subject</b>: <a href=\"Patient-PatientExample6.html\">Patient/PatientExample6</a> &quot;&quot;</p><p><b>effective</b>: 2020-07-22 16:58:05+0000</p><p><b>reasonCode</b>: Cancer (CMS/HCC) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#363346000 &quot;Malignant neoplastic disease (disorder)&quot;; <a href=\"http://terminology.hl7.org/5.0.0/CodeSystem-icd10CM.html\">International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM)</a>#C80.1 &quot;Malignant (primary) neoplasm, unspecified&quot;)</span></p><p><b>request</b>: <a href=\"MedicationRequest-MedicationRequest-Etoposide-Example.html\">MedicationRequest/MedicationRequest-Etoposide-Example</a></p><h3>Dosages</h3><table class=\"grid\"><tr><td>-</td><td><b>Route</b></td><td><b>Method</b></td><td><b>Dose</b></td></tr><tr><td>*</td><td>Intravenous route <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#47625008)</span></td><td>Inject - dosing instruction imperative (qualifier value) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#422145002)</span></td><td>73 milligram<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM code mg = 'mg')</span></td></tr></table></div>"
  },
  "status" : "completed",
  "medicationCodeableConcept" : {
    "coding" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "code" : "4179",
        "display" : "etoposide"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "code" : "310248",
        "display" : "etoposide 20 MG/ML Injectable Solution"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "code" : "362972",
        "display" : "etoposide Injectable Solution [Vepesid]"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "code" : "206832",
        "display" : "etoposide 20 MG/ML Injectable Solution [Vepesid]"
      }
    ],
    "text" : "ETOPOSIDE 20 MG/ML IV SOLN"
  },
  "subject" : {
    "reference" : "Patient/PatientExample6"
  },
  "effectiveDateTime" : "2020-07-22T16:58:05Z",
  "reasonCode" : [
    {
      "coding" : [
        {
          "system" : "http://snomed.info/sct",
          "code" : "363346000",
          "display" : "Malignant neoplastic disease (disorder)"
        },
        {
          "system" : "http://hl7.org/fhir/sid/icd-10-cm",
          "code" : "C80.1",
          "display" : "Malignant (primary) neoplasm, unspecified"
        }
      ],
      "text" : "Cancer (CMS/HCC)"
    }
  ],
  "request" : {
    "reference" : "MedicationRequest/MedicationRequest-Etoposide-Example"
  },
  "dosage" : {
    "route" : {
      "coding" : [
        {
          "system" : "http://snomed.info/sct",
          "code" : "47625008",
          "display" : "Intravenous route"
        }
      ]
    },
    "method" : {
      "coding" : [
        {
          "system" : "http://snomed.info/sct",
          "code" : "422145002",
          "display" : "Inject - dosing instruction imperative (qualifier value)"
        }
      ]
    },
    "dose" : {
      "value" : 73,
      "unit" : "milligram",
      "system" : "http://unitsofmeasure.org",
      "code" : "mg"
    }
  }
}